[Remote] Medical Science Liaison (MSL) Neurology – Northeast at Vor Bio

Remote

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Strong scientific acumen and ability to translate complex data into meaningful discussions with external experts
Excellent relationship-building skills and comfort engaging with neurologists, researchers, and healthcare providers
Familiarity with the U.S. healthcare environment, spanning academic and community neurology practices
Ability to collaborate effectively across diverse internal functions and work independently
Experience in scientific communication, education, or advocacy is preferred
Strong understanding of clinical trial operations and site engagement
Ability to adapt communication and engagement style to address the needs of both academic centers and community neurology practices
Experience in KOL (Key Opinion Leader) engagement and stakeholder engagement is preferred
Strong analytical and problem-solving skills
Ability to work in a fast-paced environment and meet deadlines

Responsibilities

Build and maintain expertise in the company’s neurology pipeline, disease biology, and evolving treatment landscape
Serve as a trusted scientific resource for internal colleagues and external stakeholders
Partner across Medical Affairs, Clinical Development, and Commercial to align strategies with scientific and patient community needs
Identify opportunities to contribute to scientific communication and evidence generation, including publications, education initiatives, and advisory programs
Establish and nurture relationships with key opinion leaders, investigators, and clinical specialists in neurology
Facilitate transparent, non-promotional scientific exchange on disease awareness, diagnostics, investigational therapies, and broader therapeutic landscape
Engage investigators and clinical trial sites to support enrollment, protocol understanding, and research collaboration
Contribute to evidence generation through IIS (Institutional Review Board) and outcomes research collaborations
Adapt communication and engagement style to address the needs of both academic centers and community neurology practices
Support advisory boards, educational initiatives, and training programs to strengthen medical and scientific capabilities across the organization

Skills

Vor Bio

Develops targeted therapies for blood cancers

About Vor Bio

Vor Biopharma focuses on developing treatments for blood cancers, particularly Acute Myeloid Leukemia (AML). Their approach is designed to protect healthy cells while specifically targeting and eliminating cancerous cells. This method aims to improve the effectiveness of blood cancer treatments. Vor Biopharma serves patients with blood cancers, their caregivers, and medical professionals in hospitals and oncology centers. What sets Vor Biopharma apart from competitors is their strong emphasis on research and development, investing significantly in scientific research to create a proprietary platform and pipeline of therapies. They generate revenue through partnerships with other pharmaceutical companies and licensing agreements, with the goal of commercializing their therapies after obtaining regulatory approval. The company's mission is to transform the treatment landscape for blood cancers by providing innovative therapies that prioritize patient safety and efficacy.

Cambridge, MassachusettsHeadquarters

2015Year Founded

$147.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Vacation

Parental Leave

401(k) Retirement Plan

401(k) Company Match

Commuter Benefits

Risks

Significant YTD price decline of -62.76% may affect investor confidence.

Key clinical trial data updates are not expected until 2025, causing uncertainty.

Increased competition from companies like Editas Medicine poses potential conflicts.

Differentiation

Vor Bio focuses on protecting healthy cells while targeting cancerous ones.

The company specializes in innovative treatments for blood cancers like AML.

Vor Bio's approach aligns with the rise of personalized medicine.

Upsides

Recent $55.6M funding supports clinical trials and extends cash runway to 2025.

FDA's acceptance of gene therapies may ease approval for Vor Bio's treatments.

Advancements in CRISPR technology enhance precision of Vor Bio's gene editing.

Land your dream remote job 3x faster with AI

Try Jobo Free